IDEXX Laboratories (NASDAQ: IDXX)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-02 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.260 | 2.270 | 0.0100 | ||||
REV | 839.720M | 836.549M | -3.171M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of IDEXX Laboratories (NASDAQ: IDXX) through any online brokerage.
Other companies in IDEXX Laboratories’s space includes: Steris (NYSE:STE), Masimo (NASDAQ:MASI), Envista Holdings (NYSE:NVST), Koninklijke Philips (NYSE:PHG) and Smith & Nephew (NYSE:SNN).
The latest price target for IDEXX Laboratories (NASDAQ: IDXX) was reported by Stifel on Friday, June 24, 2022. The analyst firm set a price target for 500.00 expecting IDXX to rise to within 12 months (a possible 33.26% upside). 10 analyst firms have reported ratings in the last year.
The stock price for IDEXX Laboratories (NASDAQ: IDXX) is $375.22 last updated July 6, 2022, 8:00 PM UTC.
There are no upcoming dividends for IDEXX Laboratories.
IDEXX Laboratories’s Q2 earnings are confirmed for Tuesday, August 2, 2022.
There is no upcoming split for IDEXX Laboratories.
IDEXX Laboratories is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.